FDA Adverse Event Injury Summary report: N

PRODIGY AUTOCODE

MDR report key: 6259255 · Received January 17, 2017

Report

Report Number
3005862821-2017-00009
Event Type
Injury
Date Received
January 17, 2017
Date of Event
December 15, 2016
Report Date
December 15, 2016
Manufacturer
OK BIOTECH CO., LTD.
Product Code
NBW
PMA / PMN Number
K073118
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SUSPECTED DEVICE EVALUATED BY OK BIOTECH AND CALCULATED THAT THE METER OPERATED WITHIN SPECIFICATIONS. THE STANDBY CURRENT TEST IS 1.0UA. THE CRITERIA IS <55UA. PASS; METER SETTING, AUDIO AND ALL BUTTONS FUNCTION ARE OK; TESTED THE SUSPECTED METER WITH IN HOUSE CONTROL SOLUTION AND RETAIN STRIPS (STRIP LOT NUMBER:D150110-2). THE CONTROL SOLUTION TESTS FOR LEVEL LOW ARE 64/66 MG/DL, FOR LEVEL HIGH ARE 275/271 MG/DL. THE REQUEST CONTROL SOLUTION RANGES ARE: LEVEL LOW 25~70 MG/DL; LEVEL HIGH 210~310 MG/DL. ALL RESULTS WERE WITHIN THE ACCEPTANCE RANGE. PASS; THE STRIP LOT #D150110-2 WAS MANUFACTURED ON 01/10/2015 AND EXPIRED IN 01/10/2017. OK BIOTECH RECEIVED NO COMPLAINTS FROM SAME MANUFACTURING BATCH OF STRIPS .

Description of Event or Problem · 1

IT WAS REPORTED THAT MEDICAL ATTENTION WAS SOUGHT ON (B)(6) 2016 AT 7:30 AM AFTER THE END USER COULD NOT BE AWAKEN FROM HER SLEEP. AT THAT MOMENT A BLOOD GLUCOSE TEST WAS PERFORMED WITH THE PRODIGY METER WITH A RESULT OF 81 MG/DL. THE PARAMEDICS WERE CALLED AND PERFORMED A BLOOD GLUCOSE TEST WITH THEIR METER AND RECEIVED A RESULT OF 42 MG/DL. THE END USER WAS TRANSPORTED TO THE ER AND COULD NOT REMEMBER WHAT TREATMENT WAS ADMINISTERED TO ASSIST WITH STABILIZING HER BLOOD GLUCOSE LEVELS. UPON DISCHARGE THE END USER WAS INSTRUCTED TO DECREASE HER LEVEMIR TO 5 UNITS AND EAT A SNACK BEFORE BED. NO ADDITIONAL INFORMATION WAS PROVIDED AS IT RELATES TO THE MEDICAL EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
41353 PRODIGY AUTOCODE BLOOD GLUCOSE MONITORING DEVICE NBW OK BIOTECH CO., LTD. 51850 54800 - D150110-2

Patients

Seq Age Sex Outcome Treatment
1 78 YR Required Intervention AMLODIPINE| ASPIRIN| BUMETANIDE| CALCITRIOL| CITALOPRAM| GABAPENTIN| HYDRALAZINE| HYDROCODONE| IRON| ISOSORBIDE| LEVEMIR E. INITIAL| NOVOLOG| OMEGA 3| PRAVASTATIN| VITAMIN D3